Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

Aitziber BuquéINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, France

Norma BloyINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, France

Fernando ArandaGroup of Immune receptors of the Innate and Adaptive System, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Isabelle CremerINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 13, Centre de Recherche des Cordeliers, Paris, France

Alexander EggermontGustave Roussy Cancer Campus, Villejuif, France

Wolf Hervé FridmanINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 13, Centre de Recherche des Cordeliers, Paris, France

Jitka FucikovaSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic

Jérôme GalonINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France

Radek SpisekSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic

Eric TartourUniversité Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;INSERM, U970, Paris, France;Paris-Cardiovascular Research Center (PARCC), Paris, France;Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France

Laurence ZitvogelGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1015, CICBT507, Villejuif, France

Guido KroemerINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]

Lorenzo GalluzziINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, FranceCorrespondence[email protected]

show all

Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

Table 1. Clinical trials recently started to assess the safety and efficacy of small molecules targeting the tumor microenvironment for oncological applications*.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

Figures & data

Table 1. Clinical trials recently started to assess the safety and efficacy of small molecules targeting the tumor microenvironment for oncological applications*.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date